Angiotensin II and the development of insulin resistance: Implications for diabetes
Review
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Angiotensin II (Ang II), the major effector hormone of the renin-angiotensin system (RAS), has an important role in the regulation of vascular and renal homeostasis. Clinical and pharmacological studies have recently shown that Ang II is a critical promoter of insulin resistance and diabetes mellitus type 2. Ang II exerts its actions on insulin-sensitive tissues such as liver, muscle and adipose tissue where it has effects on the insulin receptor (IR), insulin receptor substrate (IRS) proteins and the downstream effectors PI3K, Akt and GLUT4. The molecular mechanisms involved have not been completely identified, but the role of serine/threonine phosphorylation of the IR and IRS-1 proteins in desensitization of insulin action has been well established. The purpose of this review is to highlight recent advances in the understanding of Ang II actions which lead to the development of insulin resistance and its implications for diabetes. © 2008 Elsevier Ireland Ltd. All rights reserved.
publication date
funding provided via
published in
Research
keywords
-
Angiotensin II; Insulin; Insulin resistance; Renin-angiotensin system; Type 2 diabetes mellitus angiotensin II; angiotensin receptor antagonist; dipeptidyl carboxypeptidase inhibitor; glucose transporter 1; insulin receptor; insulin receptor substrate 1; phosphatidylinositol 3 kinase; serine; threonine; cardiovascular system; diabetes mellitus; homeostasis; human; insulin resistance; insulin sensitivity; molecular dynamics; non insulin dependent diabetes mellitus; nonhuman; phosphorylation; priority journal; renin angiotensin aldosterone system; review; Angiotensin II; Diabetes Mellitus; Humans; Insulin Resistance; Renin-Angiotensin System
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue